| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-12 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-11 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |